GlassScriptPhysician profile
Nandesh N Patel
NPI 1821292228
$2,193.88
in general payments reported to CMS, 2019-2025
20 companies · $369 in 2025
The $369 reported for 2025 was less than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $134 · 2021: $233 · 2022: $379 · 2023: $339 · 2024: $502 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,209.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $537.01 | 2019-2025 | Vabysmo |
| Regeneron Healthcare Solutions, INC. | $254.31 | 2019-2024 | Eylea Hd |
| Astellas Pharma US INC | $209.65 | 2023-2025 | Izervay |
| Notal Vision, INC. | $207.68 | 2022-2024 | Foresee Home |
| Apellis Pharmaceuticals, INC. | $191.55 | 2022-2025 | Syfovre |
| Allergan, INC. | $170.34 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $115.64 | 2023-2024 | Acthar |
| Novartis Pharmaceuticals Corporation | $87.72 | 2019-2021 | |
| Ani Pharmaceuticals, INC. | $76.70 | 2025 | Iluvien |
| Harrow Eye, LLC | $73.30 | 2025 | Iheezo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $43.24 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $41.89 | 2022-2023 | Xipere |
| Alimera Sciences, INC. | $39.34 | 2019-2022 | |
| Amgen INC. | $30.88 | 2025 | Tepezza |
| Abbvie INC. | $29.92 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coherus Oncology, INC. | $24.21 | 2023 | |
| Tarsus Pharmaceuticals, INC. | $18.39 | 2024 | Xdemvy |
| Eyepoint US, INC. | $16.50 | 2019 | |
| Oyster Point Pharma, INC. | $14.03 | 2022 | |
| Aerie Pharmaceuticals, INC. | $11.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nandesh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.